Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Blankestijn

Showing results (51-60 of 262) with videos related to

Pageof 27
Sort By:
Journal of the American Society of Nephrology : JASN|October 27, 2004
Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failureJutta Neumann, Gerry Ligtenberg, Liam Oey, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 4, 2018
Clinical evidence on haemodiafiltrationPeter J Blankestijn, Muriel P Grooteman, Menso J Nube, et al.
Current Opinion in Nephrology and Hypertension|August 21, 2002
Pathogenesis and treatment of hypertension in polycystic kidney diseaseJutta Neumann, Gerry Ligtenberg, Inge H H T Klein, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 9, 2008
Short-term sympathetic baroreflex sensitivity increases at lower blood pressuresLeonard J van Schelven, John M Karemaker, Peter J Blankestijn, et al.
Kidney International|April 17, 2004
Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatmentJutta Neumann, Gerry Ligtenberg, Inge I Klein, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 9, 2014
Inhibition of the renin-angiotensin system affects kidney tissue oxygenation evaluated by magnetic resonance imaging in patients with chronic kidney diseaseLaima Siddiqi, Hans Hoogduin, Freddy Visser, et al.
Journal of Hypertension|May 9, 2014
Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?Esther de Beus, Rosa de Jager, Jaap A Joles, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2008
Results from the RISCAVID study: is haemodiafiltration associated with improved survival?E Lars Penne, Neelke C van der Weerd, Muriel P Grooteman, et al.
British Journal of Clinical Pharmacology|August 18, 2017
Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trialRosa L de Jager, Erik M van Maarseveen, Michiel L Bots, et al.
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft|December 1, 2015
The morphological substrate for Renal Denervation: Nerve distribution patterns and parasympathetic nerves. A post-mortem histological studyWouter A C van Amsterdam, Peter J Blankestijn, Roel Goldschmeding, et al.
Pageof 27

Showing results (51-60 of 262) with videos related to

Sort By:
Pageof 27
Journal of the American Society of Nephrology : JASN|October 27, 2004
Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failureJutta Neumann, Gerry Ligtenberg, Liam Oey, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 4, 2018
Clinical evidence on haemodiafiltrationPeter J Blankestijn, Muriel P Grooteman, Menso J Nube, et al.
Current Opinion in Nephrology and Hypertension|August 21, 2002
Pathogenesis and treatment of hypertension in polycystic kidney diseaseJutta Neumann, Gerry Ligtenberg, Inge H H T Klein, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 9, 2008
Short-term sympathetic baroreflex sensitivity increases at lower blood pressuresLeonard J van Schelven, John M Karemaker, Peter J Blankestijn, et al.
Kidney International|April 17, 2004
Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatmentJutta Neumann, Gerry Ligtenberg, Inge I Klein, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 9, 2014
Inhibition of the renin-angiotensin system affects kidney tissue oxygenation evaluated by magnetic resonance imaging in patients with chronic kidney diseaseLaima Siddiqi, Hans Hoogduin, Freddy Visser, et al.
Journal of Hypertension|May 9, 2014
Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?Esther de Beus, Rosa de Jager, Jaap A Joles, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2008
Results from the RISCAVID study: is haemodiafiltration associated with improved survival?E Lars Penne, Neelke C van der Weerd, Muriel P Grooteman, et al.
British Journal of Clinical Pharmacology|August 18, 2017
Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trialRosa L de Jager, Erik M van Maarseveen, Michiel L Bots, et al.
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft|December 1, 2015
The morphological substrate for Renal Denervation: Nerve distribution patterns and parasympathetic nerves. A post-mortem histological studyWouter A C van Amsterdam, Peter J Blankestijn, Roel Goldschmeding, et al.
Pageof 27